Key result
Microsphere co-delivery of Corydalis yanhusuo and MSCs improves LVEF and reduces fibrosis after rat MI.
Why the study?
After acute MI, Corydalis yanhusuo ethanolic extract is limited by a short in vivo half-life and poor local retention, while mesenchymal stem cells suffer from low viability in the inflamed infarcted myocardium.
Does localized co-delivery of Corydalis yanhusuo ethanolic extract and mesenchymal stem cells via sodium alginate microspheres improve cardiac function and attenuate adverse ventricular remodeling in a rat model of acute myocardial infarction?
Does localized co-delivery of Corydalis yanhusuo ethanolic extract and mesenchymal stem cells via sodium alginate microspheres improve cardiac function and attenuate adverse ventricular remodeling in a rat model of acute myocardial infarction?
Preclinical proof-of-concept demonstrating that oil-free microfluidic sodium alginate microspheres co-delivering Corydalis yanhusuo extract and MSCs can sequentially modulate post-MI inflammation and enhance stem cell-mediated cardiac repair in rats.
Supports hypothesis-generating co-delivery strategies in rodent MI repair; leaves open translation to human therapy.
Persistent inflammatory responses and adverse ventricular remodeling following Acute Myocardial Infarction (MI) are critical factors driving the progressive decline of cardiac function. Traditional pharmacological strategies struggle to achieve effective long-term intervention at the level of tissue repair. The Corydalis yanhusuo ethanolic extract (CYEE) possesses demonstrated anti-inflammatory and antioxidant activities; however, its limited in vivo half-life and the difficulty in maintaining local effective concentrations hinder its efficacy. Concurrently, while mesenchymal stem cells (MSCs) exert therapeutic potential through paracrine and immunomodulatory mechanisms, their low viability within the intensely inflammatory microenvironment of the infarcted myocardium significantly restricts their clinical impact. In this study, a sodium alginate microsphere delivery system was developed using gas-assisted microfluidic technology to achieve the synergistic encapsulation and localized delivery of CYEE and MSCs. This oil-free and surfactant-free microsphere system exhibits excellent biocompatibility, enabling the sustained release of CYEE within the infarcted region to alleviate inflammation and oxidative stress for initial therapeutic intervention. Furthermore, it enhances MSCs viability and paracrine function by optimizing the local microenvironment. In vitro experiments demonstrated that the system significantly improved cell viability under inflammatory conditions and promoted migration and angiogenic capacity. In a rat MI model, synergistic delivery significantly improved cardiac function and attenuated myocardial fibrosis and adverse remodeling without evident systemic toxicity. These results indicate that combining CYEE-mediated microenvironmental regulation with the dynamic synergistic repair of MSCs provides a comprehensive therapeutic strategy with potential translational value for myocardial repair following infarction.
No takes yet. Share an insight, caveat, or question.
Dang et al. (2026) studied Acute Myocardial Infarction (LAD ligation rat model) (n=20). Sodium alginate microspheres co-delivering Corydalis yanhusuo ethanolic extract (CYEE) and mesenchymal stem cells (MSCs) vs. Untreated MI, Sham surgery, CYEE + Gel monotherapy, and MSCs + Gel monotherapy was evaluated on Echocardiographic cardiac function (Ejection Fraction [EF], Fractional Shortening [FS], LVIDd, LVIDs) and histological ventricular remodeling (infarct area percentage and wall thickness) at 28 days (p=<0.05). Co-delivery of Corydalis yanhusuo extract and MSCs via sodium alginate microspheres significantly improved ejection fraction and reduced myocardial fibrosis at 28 days in rats with MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: